{"_id": "20015871|None", "id": "20015871", "infons": {}, "passages": [{"infons": {"journal": "Haematologica; 2010 May; 95(5) 752-9. doi:10.3324/haematol.2009.016303", "year": "2010", "article-id_pmc": "PMC2864381", "type": "title", "authors": "te Winkel ML, van Beek RD, de Muinck Keizer-Schrama SM, Uitterlinden AG, Hop WC, Pieters R, van den Heuvel-Eibrink MM", "section": "Title"}, "offset": 0, "text": "Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia.", "sentences": [], "annotations": [{"id": "1", "infons": {"identifier": "MESH:D054198", "type": "Disease"}, "text": "lymphoblastic leukemia", "locations": [{"offset": 102, "length": 22}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 126, "text": "BACKGROUND: This study investigates pharmacogenetic risk factors for bone mineral (apparent) density (BM(A)D) and body composition in pediatric acute lymphoblastic leukemia DESIGN AND METHODS: We determined the influence of SNPs in 4 genes (vitamin-D receptor (VDR: BsmI/ApaI/TaqI and Cdx-2/GATA), collagen type I alpha 1 (SpI), estrogen receptor 1 (ESR1: PvuII/XbaI), glucocorticoid receptor (BclI)) on body composition, BM(A)D and fracture risk during dexamethasone-based pediatric acute lymphoblastic leukemia treatment. Body composition and BMD were measured repeatedly during and after treatment using dual energy X-ray absorptiometry. RESULTS: Non-carriers of VDR 5'-end (Cdx-2/GATA) haplotype 3 revealed a significant larger fat gain than carriers (Delta%fat: non-carriers: +1.76SDS, carriers: +0.77SDS, P&lt;0.001). At diagnosis and during therapy, lumbar spine BMD was significantly higher in non-carriers of VDR 5'-end (Cdx-2/GATA) haplotype 3 than in carriers. The other SNPs did not influence BMD or fracture risk during/after treatment. The year after treatment completion, lean body mass increased in non-carriers of ESR1 (PvuII/XbaI) haplotype 3 and decreased in carriers (Delta lean body mass: non-carriers:+0.28SDS, carriers: -0.55SDS, P&lt;0.01). CONCLUSIONS: Only VDR 5'-end (Cdx-2/GATA) haplotype 3 was identified as protective factor against excessive fat gain and as a risk factor for lower lumbar spine BMD during treatment. Carrying ESR1 (PvuII/XbaI) haplotype 3 negatively influenced recovery of lean body mass after pediatric acute lymphoblastic leukemia treatment.", "sentences": [], "annotations": [{"id": "31", "infons": {"identifier": "MESH:D054198", "type": "Disease"}, "text": "lymphoblastic leukemia", "locations": [{"offset": 276, "length": 22}]}, {"id": "32", "infons": {"identifier": "7421", "type": "Gene", "ncbi_homologene": "37297"}, "text": "vitamin-D receptor", "locations": [{"offset": 367, "length": 18}]}, {"id": "33", "infons": {"identifier": "7421", "type": "Gene", "ncbi_homologene": "37297"}, "text": "VDR", "locations": [{"offset": 387, "length": 3}]}, {"id": "34", "infons": {"identifier": "1045", "type": "Gene", "ncbi_homologene": "968"}, "text": "Cdx-2", "locations": [{"offset": 411, "length": 5}]}, {"id": "35", "infons": {"identifier": "55278", "type": "Gene", "ncbi_homologene": "6699"}, "text": "GATA", "locations": [{"offset": 417, "length": 4}]}, {"id": "36", "infons": {"identifier": "1277", "type": "Gene", "ncbi_homologene": "73874"}, "text": "collagen type I alpha 1", "locations": [{"offset": 424, "length": 23}]}, {"id": "37", "infons": {"identifier": "1113", "type": "Gene", "ncbi_homologene": "976"}, "text": "SpI", "locations": [{"offset": 449, "length": 3}]}, {"id": "38", "infons": {"identifier": "2099", "type": "Gene", "ncbi_homologene": "47906"}, "text": "estrogen receptor 1", "locations": [{"offset": 455, "length": 19}]}, {"id": "39", "infons": {"identifier": "2099", "type": "Gene", "ncbi_homologene": "47906"}, "text": "ESR1", "locations": [{"offset": 476, "length": 4}]}, {"id": "40", "infons": {"identifier": "2908", "type": "Gene", "ncbi_homologene": "30960"}, "text": "glucocorticoid receptor", "locations": [{"offset": 495, "length": 23}]}, {"id": "41", "infons": {"identifier": "MESH:D050723", "type": "Disease"}, "text": "fracture", "locations": [{"offset": 559, "length": 8}]}, {"id": "42", "infons": {"identifier": "MESH:D054198", "type": "Disease"}, "text": "lymphoblastic leukemia", "locations": [{"offset": 616, "length": 22}]}, {"id": "43", "infons": {"identifier": "MESH:D020388", "type": "Disease"}, "text": "BMD", "locations": [{"offset": 671, "length": 3}]}, {"id": "44", "infons": {"identifier": "7421", "type": "Gene", "ncbi_homologene": "37297"}, "text": "VDR", "locations": [{"offset": 792, "length": 3}]}, {"id": "45", "infons": {"identifier": "1045", "type": "Gene", "ncbi_homologene": "968"}, "text": "Cdx-2", "locations": [{"offset": 804, "length": 5}]}, {"id": "46", "infons": {"identifier": "55278", "type": "Gene", "ncbi_homologene": "6699"}, "text": "GATA", "locations": [{"offset": 810, "length": 4}]}, {"id": "47", "infons": {"identifier": "MESH:D020388", "type": "Disease"}, "text": "BMD", "locations": [{"offset": 996, "length": 3}]}, {"id": "48", "infons": {"identifier": "7421", "type": "Gene", "ncbi_homologene": "37297"}, "text": "VDR", "locations": [{"offset": 1044, "length": 3}]}, {"id": "49", "infons": {"identifier": "1045", "type": "Gene", "ncbi_homologene": "968"}, "text": "Cdx-2", "locations": [{"offset": 1056, "length": 5}]}, {"id": "50", "infons": {"identifier": "55278", "type": "Gene", "ncbi_homologene": "6699"}, "text": "GATA", "locations": [{"offset": 1062, "length": 4}]}, {"id": "51", "infons": {"identifier": "MESH:D020388", "type": "Disease"}, "text": "BMD", "locations": [{"offset": 1131, "length": 3}]}, {"id": "52", "infons": {"identifier": "MESH:D050723", "type": "Disease"}, "text": "fracture", "locations": [{"offset": 1138, "length": 8}]}, {"id": "53", "infons": {"identifier": "2099", "type": "Gene", "ncbi_homologene": "47906"}, "text": "ESR1", "locations": [{"offset": 1257, "length": 4}]}, {"id": "54", "infons": {"identifier": "7421", "type": "Gene", "ncbi_homologene": "37297"}, "text": "VDR", "locations": [{"offset": 1409, "length": 3}]}, {"id": "55", "infons": {"identifier": "1045", "type": "Gene", "ncbi_homologene": "968"}, "text": "Cdx-2", "locations": [{"offset": 1421, "length": 5}]}, {"id": "56", "infons": {"identifier": "55278", "type": "Gene", "ncbi_homologene": "6699"}, "text": "GATA", "locations": [{"offset": 1427, "length": 4}]}, {"id": "57", "infons": {"identifier": "MESH:D020388", "type": "Disease"}, "text": "BMD", "locations": [{"offset": 1552, "length": 3}]}, {"id": "58", "infons": {"identifier": "2099", "type": "Gene", "ncbi_homologene": "47906"}, "text": "ESR1", "locations": [{"offset": 1583, "length": 4}]}, {"id": "59", "infons": {"identifier": "MESH:D054198", "type": "Disease"}, "text": "lymphoblastic leukemia", "locations": [{"offset": 1684, "length": 22}]}], "relations": []}], "relations": [], "pmid": 20015871, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@2099", "gene@1045", "gene@1113", "gene@7421", "gene@2908", "gene@55278", "disease@MESH:D050723", "disease@MESH:D020388", "gene@1277", "disease@MESH:D054198"], "journal": "Haematologica", "year": 2010, "authors": ["te Winkel ML", "van Beek RD", "de Muinck Keizer-Schrama SM", "Uitterlinden AG", "Hop WC", "Pieters R", "van den Heuvel-Eibrink MM"]}
